Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · Real-Time Price · USD
2.810
+0.145 (5.44%)
At close: Apr 1, 2025, 4:00 PM
2.670
-0.140 (-4.98%)
After-hours: Apr 1, 2025, 4:38 PM EDT
Scinai Immunotherapeutics Market Cap
Scinai Immunotherapeutics has a market cap or net worth of $2.40 million as of April 1, 2025. Its market cap has increased by 33.16% in one year.
Market Cap
2.40M
Enterprise Value
2.49M
1-Year Change
33.16%
Ranking
Category
Stock Price
$2.81
Market Cap Chart
Since May 12, 2015, Scinai Immunotherapeutics's market cap has decreased from $11.20M to $2.40M, a decrease of -78.60%. That is a compound annual growth rate of -14.43%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 31, 2025 | 2.30M | -20.69% |
Dec 31, 2024 | 2.90M | 31.82% |
Dec 29, 2023 | 2.20M | -60.00% |
Dec 30, 2022 | 5.50M | -83.68% |
Dec 31, 2021 | 33.70M | 5.64% |
Dec 31, 2020 | 31.90M | -65.85% |
Dec 31, 2019 | 93.40M | 199.36% |
Dec 31, 2018 | 31.20M | 72.38% |
Dec 29, 2017 | 18.10M | 60.18% |
Dec 30, 2016 | 11.30M | 0.89% |
Dec 31, 2015 | 11.20M | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 738.61B |
UnitedHealth Group | 472.03B |
Johnson & Johnson | 394.52B |
AbbVie | 363.15B |
Novo Nordisk | 305.46B |
AstraZeneca | 229.16B |
Abbott Laboratories | 226.88B |
Merck & Co. | 225.40B |